Literature DB >> 6661163

The effect of a long-acting adenosine analog on blood flow through various organs in the dog.

W Schütz, O Kraupp, S Bacher, G Raberger.   

Abstract

Radioactively labeled microspheres were used to investigate the effect of 2',3'-di-O-nitro-5'-(N-ethylcarboxamido)-adenosine (10 micrograms/kg orally), a long-acting adenosine analog, on blood flow through various organs over an experimental period of three hours in conscious dogs. There was a significant increase in myocardial, cerebral, intestinal, and renal cortical blood flow, whereas the flow through skeletal muscle, liver, pancreas, and renal medulla was unaffected. The endocardial/epicardial flow ratio, which was more than one under control conditions, decreased significantly. Arterial blood pressure and heart rate remained virtually unchanged. Since the adenosine analog is rapidly and completely denitrated in vivo, the denitration product 5'-(N-ethylcarboxamide)-adenosine, a highly potent adenosine receptor agonist, must be considered as the vasoactive metabolite.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661163     DOI: 10.1007/bf01907215

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  13 in total

1.  The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart.

Authors:  A N Drury; A Szent-Györgyi
Journal:  J Physiol       Date:  1929-11-25       Impact factor: 5.182

2.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

3.  Metabolically linked vasoactive chemicals in local regulation of blood flow.

Authors:  F J Haddy; J B Scott
Journal:  Physiol Rev       Date:  1968-10       Impact factor: 37.312

4.  [Dosage-effect relations between coronary blood flow and heart rate for adenosine].

Authors:  H Schöndorf; W Rummel; K Pfleger
Journal:  Experientia       Date:  1969-01-15

5.  Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels.

Authors:  W Schütz; G Steurer; E Tuisl
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

6.  Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs.

Authors:  H Osswald; W S Spielman; F G Knox
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

7.  Coronary dilatory action of adenosine analogues: a comparative study.

Authors:  G Raberger; W Schütz; O Kraupp
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-11

8.  Regional myocardial blood flow in awake dogs.

Authors:  F R Cobb; R J Bache; J C Greenfield
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

9.  Metabolism and disposition of 2',3'-di-O-nitro-adenosine-5'-(N-ethyl-carboxamide) in dogs.

Authors:  H Wiener; P Krivanek; N Kolassa
Journal:  Biochem Pharmacol       Date:  1983-06-15       Impact factor: 5.858

10.  Cardiovascular and metabolic actions of an adenosine analogue (2'3'-o-methoxy-ethyliden-adenosine-5'-ethylcarboxamide) in the conscious dog.

Authors:  G Raberger; W Schütz; O Kraupp
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.